CCM
BIIB icon

Channing Capital Management’s Biogen BIIB Stock Holding History

Channing Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36,974
Closed -$7.17M – 110
2024
Q3 		$7.17M Sell
36,974
-691
-2% -$145K 0.18% 96
2024
Q2 		$8.73M Sell
37,665
-738
-2% -$160K 0.24% 75
2024
Q1 		$8.28M Buy
38,403
+4,300
+13% +$1.01M 0.22% 81
2023
Q4 		$8.82M Buy
34,103
+4,077
+14% +$1M 0.26% 66
2023
Q3 		$7.72M Buy
+30,026
New +$8.03M 0.25% 71
2018
Q3 		– Sell
-26,500
Closed -$7.69M – 104
2018
Q2 		$7.69M Sell
26,500
-3,729
-12% -$1.05M 0.27% 77
2018
Q1 		$8.28M Buy
30,229
+4,468
+17% +$1.39M 0.29% 74
2017
Q4 		$8.21M Buy
25,761
+1
+0% +$321 0.28% 77
2017
Q3 		$8.07M Sell
25,760
-897
-3% -$266K 0.3% 78
2017
Q2 		$7.23M Buy
26,657
+1,909
+8% +$505K 0.28% 79
2017
Q1 		$6.77M Buy
24,748
+1,725
+7% +$488K 0.25% 84
2016
Q4 		$6.53M Sell
23,023
-7,113
-24% -$2.11M 0.23% 85
2016
Q3 		$9.43M Hold
30,136
– – 0.38% 66
2016
Q2 		$7.29M Buy
30,136
+6,883
+30% +$1.81M 0.31% 81
2016
Q1 		$6.05M Buy
+23,253
New +$6.14M 0.27% 79

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Channing Capital Management's BIIB Position: Q4 2024 in Review

Channing Capital Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 36,974 shares — an estimated $7.17M sold.

Channing Capital Management first reported a position in BIIB in Q1 2016 and held it in 15 quarters. The position peaked at $9.43M in Q3 2016. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Channing Capital Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Channing Capital Management sold 36,974 Biogen shares in Q4 2024, an estimated $7.17M.
  • Channing Capital Management first reported a position in Biogen in Q1 2016 and held it in 15 quarters.
  • Channing Capital Management's Biogen position peaked at $9.43M in Q3 2016.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Channing Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.